Chen T et al., found that emodin ameliorated glucose-induced EMT and subsequent podocyte dysfunction partly through integrin-linked kinase (ILK), which might provide a potential novel therapeutic option for diabetic kidney disease [42]. The gene discussed is ILK; the disease is diabetic kidney disease.